Annual EBIT
-$26.57 M
+$8.63 M+24.51%
30 September 2023
Summary:
ESSA Pharma annual earnings before interest & taxes is currently -$26.57 million, with the most recent change of +$8.63 million (+24.51%) on 30 September 2023. During the last 3 years, it has risen by +$10.24 million (+27.82%). EPIX annual EBIT is now -1430.48% below its all-time high of -$1.71 million.EPIX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$7.23 M
+$1.76 M+19.53%
30 June 2024
Summary:
ESSA Pharma quarterly earnings before interest & taxes is currently -$7.23 million, with the most recent change of +$1.76 million (+19.53%) on 30 June 2024. Over the past year, it has dropped by -$1.75 million (-32.00%). EPIX quarterly EBIT is now -282.93% below its all-time high of $3.95 million, reached on 30 June 2017.EPIX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$27.67 M
+$63.60 K+0.23%
30 June 2024
Summary:
ESSA Pharma TTM earnings before interest & taxes is currently -$27.67 million, with the most recent change of +$63.60 thousand (+0.23%) on 30 June 2024. Over the past year, it has dropped by -$1.09 million (-4.12%). EPIX TTM EBIT is now -11846.33% below its all-time high of -$231.60 thousand, reached on 31 December 2013.EPIX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPIX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -32.0% | -4.1% |
| 3 y3 years | +27.8% | +15.4% | +24.9% |
| 5 y5 years | -119.3% | -126.3% | -128.4% |
EPIX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.8% | -32.0% | +33.3% | -7.3% | +29.7% |
| 5 y | 5 years | -119.3% | +27.8% | -126.3% | +44.2% | -128.4% | +29.7% |
| alltime | all time | -1430.5% | +27.8% | -282.9% | +44.2% | <-9999.0% | +29.7% |
ESSA Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$7.23 M(-19.5%) | -$27.67 M(-0.2%) |
| Mar 2024 | - | -$8.99 M(+50.7%) | -$27.73 M(+7.5%) |
| Dec 2023 | - | -$5.96 M(+8.8%) | -$25.80 M(-2.9%) |
| Sept 2023 | -$26.57 M(-24.5%) | -$5.48 M(-24.9%) | -$26.57 M(-3.3%) |
| June 2023 | - | -$7.30 M(+3.4%) | -$27.48 M(-5.4%) |
| Mar 2023 | - | -$7.06 M(+4.7%) | -$29.05 M(-11.6%) |
| Dec 2022 | - | -$6.74 M(+5.5%) | -$32.85 M(-6.7%) |
| Sept 2022 | -$35.20 M(-4.4%) | -$6.39 M(-28.0%) | -$35.20 M(-5.8%) |
| June 2022 | - | -$8.87 M(-18.3%) | -$37.37 M(+0.4%) |
| Mar 2022 | - | -$10.85 M(+19.3%) | -$37.23 M(-5.4%) |
| Dec 2021 | - | -$9.09 M(+6.3%) | -$39.35 M(+6.9%) |
| Sept 2021 | -$36.82 M(+59.3%) | -$8.56 M(-2.1%) | -$36.82 M(+12.5%) |
| June 2021 | - | -$8.73 M(-32.6%) | -$32.71 M(+14.0%) |
| Mar 2021 | - | -$12.96 M(+97.6%) | -$28.71 M(+14.8%) |
| Dec 2020 | - | -$6.56 M(+47.4%) | -$25.00 M(+8.2%) |
| Sept 2020 | -$23.12 M(+90.8%) | -$4.45 M(-5.9%) | -$23.12 M(+5.7%) |
| June 2020 | - | -$4.73 M(-49.0%) | -$21.86 M(+7.8%) |
| Mar 2020 | - | -$9.26 M(+98.1%) | -$20.28 M(+42.1%) |
| Dec 2019 | - | -$4.68 M(+46.3%) | -$14.27 M(+17.8%) |
| Sept 2019 | -$12.12 M | -$3.20 M(+1.6%) | -$12.12 M(+10.3%) |
| June 2019 | - | -$3.15 M(-3.2%) | -$10.98 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.25 M(+28.8%) | -$10.47 M(-7.9%) |
| Dec 2018 | - | -$2.52 M(+22.2%) | -$11.37 M(+6.3%) |
| Sept 2018 | -$10.69 M(+197.1%) | -$2.06 M(-21.6%) | -$10.69 M(+3.5%) |
| June 2018 | - | -$2.63 M(-36.5%) | -$10.33 M(+176.3%) |
| Mar 2018 | - | -$4.15 M(+124.7%) | -$3.74 M(-46.5%) |
| Dec 2017 | - | -$1.85 M(+8.6%) | -$6.98 M(+94.1%) |
| Sept 2017 | -$3.60 M(-70.1%) | -$1.70 M(-143.0%) | -$3.60 M(-40.5%) |
| June 2017 | - | $3.95 M(-153.5%) | -$6.04 M(-56.2%) |
| Mar 2017 | - | -$7.39 M(-580.2%) | -$13.81 M(+110.5%) |
| Dec 2016 | - | $1.54 M(-137.1%) | -$6.56 M(-45.6%) |
| Sept 2016 | -$12.05 M(+25.8%) | -$4.15 M(+8.8%) | -$12.05 M(+63.2%) |
| June 2016 | - | -$3.81 M(+2586.2%) | -$7.39 M(-16.5%) |
| Mar 2016 | - | -$141.90 K(-96.4%) | -$8.85 M(-27.7%) |
| Dec 2015 | - | -$3.95 M(-861.2%) | -$12.23 M(+27.6%) |
| Sept 2015 | -$9.58 M(+451.9%) | $519.10 K(-109.8%) | -$9.58 M(-9.1%) |
| June 2015 | - | -$5.27 M(+49.5%) | -$10.54 M(+70.0%) |
| Mar 2015 | - | -$3.53 M(+170.9%) | -$6.20 M(+121.2%) |
| Dec 2014 | - | -$1.30 M(+197.1%) | -$2.80 M(+61.8%) |
| Sept 2014 | -$1.74 M | -$438.20 K(-53.0%) | -$1.73 M(+33.9%) |
| June 2014 | - | -$932.70 K(+618.6%) | -$1.29 M(+258.1%) |
| Mar 2014 | - | -$129.80 K(-44.0%) | -$361.40 K(+56.0%) |
| Dec 2013 | - | -$231.60 K | -$231.60 K |
FAQ
- What is ESSA Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for ESSA Pharma?
- What is ESSA Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ESSA Pharma?
- What is ESSA Pharma quarterly EBIT year-on-year change?
- What is ESSA Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ESSA Pharma?
- What is ESSA Pharma TTM EBIT year-on-year change?
What is ESSA Pharma annual earnings before interest & taxes?
The current annual EBIT of EPIX is -$26.57 M
What is the all time high annual EBIT for ESSA Pharma?
ESSA Pharma all-time high annual earnings before interest & taxes is -$1.71 M
What is ESSA Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of EPIX is -$7.23 M
What is the all time high quarterly EBIT for ESSA Pharma?
ESSA Pharma all-time high quarterly earnings before interest & taxes is $3.95 M
What is ESSA Pharma quarterly EBIT year-on-year change?
Over the past year, EPIX quarterly earnings before interest & taxes has changed by -$1.75 M (-32.00%)
What is ESSA Pharma TTM earnings before interest & taxes?
The current TTM EBIT of EPIX is -$27.67 M
What is the all time high TTM EBIT for ESSA Pharma?
ESSA Pharma all-time high TTM earnings before interest & taxes is -$231.60 K
What is ESSA Pharma TTM EBIT year-on-year change?
Over the past year, EPIX TTM earnings before interest & taxes has changed by -$1.09 M (-4.12%)